3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase 3
1
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Colorectal Neoplasms
74
Colonic Neoplasms
31
Rectal Neoplasms
29
Neoplasm Metastasis
15
Stomach Neoplasms
12
Pancreatic Neoplasms
11
Small Cell Lung Carcinoma
7
Esophageal Squamous Cell Carcinoma
7
Neoplasms
6
Esophageal Neoplasms
6
Rhabdomyosarcoma
4
Intestinal Neoplasms
4
Gastrointestinal Neoplasms
4
Digestive System Neoplasms
4
Uterine Cervical Neoplasms
3
Sarcoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Cholangiocarcinoma
3
Biliary Tract Neoplasms
3
Rectal Diseases
2
Neuroblastoma
2
Neoplasms by Histologic Type
2
Intestinal Diseases
2
Hepatoblastoma
2
Gastrointestinal Diseases
2
Ganglioneuroblastoma
2
Digestive System Diseases
2
Colorectal Cancer Metastatic
2
Colorectal Adenocarcinoma
2
Colonic Diseases
2
Interventions
Vincristine
5
Ifosfamide
5
Etoposide
5
Radiotherapy
4
Doxorubicin
4
Cyclophosphamide
4
Dactinomycin
3
Neoadjuvant Therapy
2
Chemotherapy, Adjuvant
2
Brachytherapy
2
etoposide phosphate
1
Topotecan
1
Temozolomide
1
Mesna
1
Melphalan
1
Irinotecan
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Fentanyl
1
FANG vaccine
1
Epirubicin
1
Dexrazoxane
1
Cyproheptadine
1
Carboplatin
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Neuroectodermal Tumors, Primitive, Peripheral
×
Irinotecan
×
Clear all
NCT03495921
2023-04-26
VITA
Gradalis, Inc.
Phase 3
Terminated
32 enrolled
13 charts